ストックスクリーナーアプリを入手
51.94
1.74%
0.89
Hims Hers Health Inc (HIMS) 最新ニュース
Why Hims & Hers Stock Sank This Week - Mitrade
HIMS Deadline: HIMS Investors Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit - The Malaysian Reserve
Class Action Filed Against Hims & Hers Health, Inc. (HIMS) Over Securities ViolationsContact Levi & Korsinsky Today - ACCESS Newswire
Class Action Lawsuit Filed: Hims & Hers Health, Inc. (HIMS)Join by August 25, 2025Contact Levi & Korsinsky - ACCESS Newswire
HIMS and the Legal Reckoning in Telehealth: Navigating the Risks of Rapid Growth in a Regulated Sector - AInvest
Capital Compounders for Investors - The Motley Fool
HIMS FINAL DEADLINE: ROSEN, A TOP RANKED LAW FIRM, - GlobeNewswire
DEADLINE ALERT for HIMS, IRBT, CNC, BHVN: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions - Morningstar
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Hims & Hers Health - The Malaysian Reserve
HIMS Shares Decline Amid Lower Revenue Per Order For GLP-1 - GlobeNewswire
Contact Levi & Korsinsky by August 25, 2025 Deadline to Join Class Action Against Hims & Hers Health, Inc.(HIMS) - PR Newswire
HIMS INVESTOR DEADLINE: Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Securities Class Action Lawsuit - PR Newswire
Hims & Hers Health’s (HIMS) Hold Rating Reiterated at Needham & Company LLC - Defense World
Leerink Partnrs Issues Negative Forecast for HIMS Earnings - Defense World
Hims & Hers: A Game-Changer in Telehealth or Just Another Fad? - The Globe and Mail
Did You Lose Money on Hims & Hers Health, Inc. (HIMS)? Levi & Korsinsky Urges Investors to Act Before August 25, 2025 - Barchart.com
HIMS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
Hims & Hers Health, Inc. (HIMS) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire
Hims & Hers Health, Inc.: Please contact the Portnoy Law - GlobeNewswire
Hims & Hers Redefines Virtual Care With Integrated Tech Platforms - Yahoo Finance
Hims & Hers: A High-Risk Bet (NYSE:HIMS) - Seeking Alpha
Hims & Hers Health, Inc. (HIMS) Class Action Lawsuit: Levi & Korsinsky Reminds Investors of August 25, 2025 Deadline - Stockhouse
HIMS Shares Decline Amid Lower Revenue Per Order For GLP-1 Following Novo Nordisk Collaboration Termination, Securities Class Action Pending — Hagens Berman - TradingView
HIMS LAWSUIT ALERT: The Gross Law Firm Notifies Hims & Hers Health, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - PR Newswire
HIMS & HERS HEALTH SHAREHOLDER ALERT: CLAIMSFILER REMINDS - GlobeNewswire
2025-08-06 | Levi & Korsinsky Urges Hims & Hers Health, Inc. (HIMS) Shareholders to Act Before Lead Plaintiff Deadline August 25, 2025 | NYSE:HIMS | Press Release - Stockhouse
Hims & Hers: From Telehealth To Wellness Hub, The Bright Future (NYSE:HIMS) - Seeking Alpha
Hims & Hers: Still Growing After Breakup With Novo Nordisk (NYSE:HIMS) - Seeking Alpha
Hims & Hers: GLP-1 Strategy Is On Dubious Grounds (NYSE:HIMS) - Seeking Alpha
Hims & Hers (HIMS) Falls 12.36% on Weaker Revenues - Insider Monkey
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Hims & Hers Health, Inc. of Class Action Lawsuit and Upcoming DeadlinesHIMS - PR Newswire
Diagnosis: Hims & Hers' August Price Dip Is an Opportunity to Buy - MarketBeat
Contact Levi & Korsinsky by August 25, 2025 to Join Class Action Against Hims & Hers Health, Inc. (HIMS) - The Globe and Mail
Hims & Hers Health, Inc. (NYSE:HIMS) Q2 2025 Earnings Call Transcript - Insider Monkey
Should You Buy Hims & Hers Stock on the Dip? - The Globe and Mail
Hims & Hers Health (NYSE:HIMS) Shares Gap Down on Disappointing Earnings - Defense World
Hims & Hers Reports Strong Growth Amid Challenges - TipRanks
HIMS LAWSUIT ALERT: Bragar Eagel & Squire, P.C. Announces - GlobeNewswire
HIMS DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages - GlobeNewswire
Palantir, Pfizer, Vertex, Hims & Hers, Coinbase, BP, and More Stock Market Movers - Barron's
Shareholders of Hims & Hers Health, Inc. Should Contact - GlobeNewswire
US Market Under Pressure: Amazon, Eastman Chemical, and Hims & Hers Among Top Losers - FinancialContent
Why Hims & Hers Health (HIMS) Faces New Questions After Revenue Guidance Miss and Regulatory Setbacks - simplywall.st
Hims & Hers Stock Slides on Earnings. Weight-Loss Drugs Are Just One Problem. - Barron's
Wait Out The GLP-1 Storm – Buy The Hims And Hers Post-Earnings Dip (NYSE:HIMS) - Seeking Alpha
Hims & Hers Stock Is Trading Lower Tuesday: What's Going On? - Benzinga
Deadline Alert: Hims & Hers Health, Inc. (HIMS) Investors - GlobeNewswire
Hims & Hers Stock Sags As Revenue Falls Short Of Hype - Finimize
HIMS Stock Plunges Following Q2 Earnings Miss, Gross Margin Down - Yahoo Finance
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Hims & Hers Health - GlobeNewswire
Hims & Hers Health Posts Weak Q2; Heading Into More Near-Term Challenges, Analysts Say - Benzinga
Why Hims & Hers Health Stock Just Dropped - Yahoo Finance
Hims & Hers Health, DuPont, Gartner: Trending Tickers - Yahoo Finance
Hims & Hers stock slides 5% after second quarter revenue misses forecasts - Yahoo Finance
0.96%
1.85%
大文字化:
|
ボリューム (24 時間):